Close Menu

NEW YORK (GenomeWeb) – An international team of researchers has used a CRISPR activation (CRISPRa) screen to identify both coding and noncoding pathways involved in acquired resistance to cytarabine, the main treatment for acute myeloid leukemia (AML).

The study, led by senior author Pier Paolo Pandolfi of the Beth Israel Deaconess Medical Center and Harvard Medical School, was published in Cell today.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers representing scientists and students of Chinese descent voice their concerns about recent US policies and rhetoric.

Wired reports that researchers have shown they could reprogram a DNA-based computer.

Researchers say increased diversity in genomic studies will benefit all, PBS NewsHour reports.

In Science this week: whole-genome sequencing of single sperm cells, and more.

Sponsored by

This webinar will provide an overview of current biomarker strategies for guiding the use of combination checkpoint immunotherapies in blood cancers.

Sponsored by

This webinar will discuss novel long-read transcript sequencing (LRTseq) methods for transcriptome annotation that could increase the efficiency and accuracy of future sequencing projects.